参考来源: [1]NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines®)Breast Cancer.Version 1.2023. [2]Partial breast irradiation versus whole breast radiotherapy for early breast cancer - Hickey, BE - 2021 | Cochrane Library https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD0070...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring 新增...
[1]NCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines®)Breast Cancer.Version 1.2023. [2]Partial breast irradiation versus whole breast radiotherapy for early breast cancer - Hickey, BE - 2021 | Cochrane Library https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007077.pub4/f...
Footnote ttt added:According to the 5th ESO-ESMO international consensus guidelines for advanced breast cancer visceral crisis is defined as: “severe organ dysfunction, as assessed by signs and symptoms, laboratory studies and rapid progression of disease. Viscera...
美国国家综合癌症网络(NCCN)指南更新了2023年第1版乳腺癌临床实践指南,针对乳腺癌的手术、放疗以及药物治疗都进行了修改。 手术治疗 1.保乳手术可行时,推荐采用保乳手术+腋窝手术分期±肿瘤整形重建治疗 对于早中期乳腺癌患者,外科手术依然是根治乳腺癌的主要手段。目前,乳腺癌外科根治手术主要有两种:乳房切除术和保乳手...
美国国家综合癌症网络(NCCN)指南更新了2023年第1版乳腺癌临床实践指南,针对乳腺癌的手术、放疗以及药物治疗都进行了修改。 手术治疗 1.保乳手术可行时,推荐采用保乳手术+腋窝手术分期±肿瘤整形重建治疗 对于早中期乳腺癌患者,外科手术依然是根治乳腺癌的主要手段。目前,乳腺癌外科根治手术主要有两种:乳房切除术和保乳手...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring ...
[1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. N Engl J Med. 2024 Oct 31;391(17):1584-1596. ...
2024年1月25日,时隔51天,美国国家综合癌症网络(NCCN)乳腺癌临床实践指南悄然由2023年第5版更新至2024年第1版,全文仍为256页。 NCCN为非国立、全国综合癌症中心联盟组织,1993年11月成立,1995年1月31日正式宣布成为全国联盟,最初由13个美国知名综合癌症中心组成,目前已经增至33个: ...
►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. 本文首发于丁香园旗下专业平台:丁香园肿瘤时间 作者:黄玉庭;编辑:Bree 题图:图虫创意 投稿:sunjiamei@dxy.cn...